Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Glynne-Jones

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Eclinicalmedicine|December 14, 2019
TNT in rectal cancer may not be the new testament?Rob Glynne-Jones
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 9, 2014
Do t3 rectal cancers always need radiochemotherapy?Rob Glynne-Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
The future of rectal cancer: let's do the right trialsRob Glynne-Jones
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 7, 2012
Neoadjuvant treatment in rectal cancer: do we always need radiotherapy-or can we risk assess locally advanced rectal cancer better?Rob Glynne-Jones
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 8, 2011
Radiotherapy and oncologyRob Glynne-Jones
The Lancet. Oncology|May 21, 2011
…and a two-edged sword in their handsRob Glynne-Jones
The Lancet. Oncology|March 4, 2021
Interpreting the RAPIDO trial: factors to considerRob Glynne-Jones
The Lancet. Gastroenterology & Hepatology|October 16, 2018
Watch and wait in rectal cancer: is it time to subclassify cT3?Rob Glynne-Jones
Diseases of the Colon and Rectum|July 7, 2017
Chemotherapy, "Lighting the Fire" or "Releasing the Brakes" in Metastatic Anal CancerRob Glynne-Jones
International Journal of Radiation Oncology, Biology, Physics|September 13, 2006
Just how useful an endpoint is complete pathological response after neoadjuvant chemoradiation in rectal cancer?Rob Glynne-Jones, Nicola Anyamene
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Eclinicalmedicine|December 14, 2019
TNT in rectal cancer may not be the new testament?Rob Glynne-Jones
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 9, 2014
Do t3 rectal cancers always need radiochemotherapy?Rob Glynne-Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
The future of rectal cancer: let's do the right trialsRob Glynne-Jones
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 7, 2012
Neoadjuvant treatment in rectal cancer: do we always need radiotherapy-or can we risk assess locally advanced rectal cancer better?Rob Glynne-Jones
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 8, 2011
Radiotherapy and oncologyRob Glynne-Jones
The Lancet. Oncology|May 21, 2011
…and a two-edged sword in their handsRob Glynne-Jones
The Lancet. Oncology|March 4, 2021
Interpreting the RAPIDO trial: factors to considerRob Glynne-Jones
The Lancet. Gastroenterology & Hepatology|October 16, 2018
Watch and wait in rectal cancer: is it time to subclassify cT3?Rob Glynne-Jones
Diseases of the Colon and Rectum|July 7, 2017
Chemotherapy, "Lighting the Fire" or "Releasing the Brakes" in Metastatic Anal CancerRob Glynne-Jones
International Journal of Radiation Oncology, Biology, Physics|September 13, 2006
Just how useful an endpoint is complete pathological response after neoadjuvant chemoradiation in rectal cancer?Rob Glynne-Jones, Nicola Anyamene
Pageof 9